These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35611229)

  • 21. Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence.
    Schuh MJ; Crosby S
    Innov Pharm; 2020; 11(2):. PubMed ID: 34007616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
    Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A
    Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy.
    Zhang L; Zhou S; Allen JD; Wang F; Pittenger AL; Bishop JR
    Clin Transl Sci; 2023 Nov; 16(11):2356-2368. PubMed ID: 37721333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implementation of preemptive pharmacogenomics in psychiatry.
    Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
    EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population structure and pharmacogenomic risk stratification in the United States.
    Nagar SD; Conley AB; Jordan IK
    BMC Biol; 2020 Oct; 18(1):140. PubMed ID: 33050895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacogenomic landscape of an Indigenous Australian population.
    Samarasinghe SR; Hoy W; Jadhao S; McMorran BJ; Guchelaar HJ; Nagaraj SH
    Front Pharmacol; 2023; 14():1180640. PubMed ID: 37284308
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing.
    Vermehren C; Søgaard Nielsen R; Jørgensen S; Drastrup AM; Westergaard N
    J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32752034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
    Reizine N; Vokes EE; Liu P; Truong TM; Nanda R; Fleming GF; Catenacci DVT; Pearson AT; Parsad S; Danahey K; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Ther Adv Med Oncol; 2020; 12():1758835920974118. PubMed ID: 33414846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
    Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
    Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
    Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
    Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
    Caspar SM; Schneider T; Meienberg J; Matyas G
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
    Zhu Y; Moriarty JP; Swanson KM; Takahashi PY; Bielinski SJ; Weinshilboum R; Wang L; Borah BJ
    Genet Med; 2021 Mar; 23(3):461-470. PubMed ID: 33041335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis.
    David V; Fylan B; Bryant E; Smith H; Sagoo GS; Rattray M
    Front Genet; 2021; 12():698148. PubMed ID: 34394187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message.
    Heukelom JV; Jacobsen K; Petry NJ; Schultz A; Baye J; Sturdevant D; Massmann A
    Pharmacogenomics; 2023 Apr; 24(6):315-323. PubMed ID: 37125619
    [No Abstract]   [Full Text] [Related]  

  • 36. Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota.
    Zhang L; Jacobson PA; Johnson ANK; Gregornik DB; Johnson SG; McCarty CA; Bishop JR
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Pharmacogenetic Drugs by the Dutch Population.
    Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
    Front Genet; 2019; 10():567. PubMed ID: 31312209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
    Cousin MA; Matey ET; Blackburn PR; Boczek NJ; McAllister TM; Kruisselbrink TM; Babovic-Vuksanovic D; Lazaridis KN; Klee EW
    Mol Genet Genomic Med; 2017 May; 5(3):269-279. PubMed ID: 28546997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations.
    Li D; Xie AH; Liu Z; Li D; Ning B; Thakkar S; Tong W; Xu J
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33113799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.